Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
C135
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/08/2021
Teicoplanin
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/06/2021
Menstrual blood-derived stem cells
Potential treatment - clinical evidence Experimental Other treatment Mar/06/2021
Hydroxyitraconazole
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021
Bis4
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021
Bis3
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/05/2021
N-[(7S)-1,2,10-Trimethoxy-9-oxo-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021
N-3-{[(7S)-7-(acetylamino)-1,2,3-trimethoxy-11-(4-methoxyphenyl)-9-oxo-5,6,7,9-tetrahydrobenzo[9,10]heptaleno[3,2-b]furan-12-yl]acetyl}-N-[(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]-beta-alaninamide
Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021
[(2S,4R)-4-Hydroxy-2-methoxy-5-[(2S)-6-oxo-2,3-dihydropyran-2-yl]pentyl] 5-oxo-5-[[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]amino]pentanoate
Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021
2-[[(2R,5R)-5-[(6R)-6-Hydroxy-5-oxo-3,3a,6,6a-tetrahydro-2H-furo[3,2-b]furan-2-yl]oxan-2-yl]-methoxyamino]-N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021
Bafilomycin A1
Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021
Nb11‐59
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/04/2021
aRBD-2-7
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
aRBD-2-5
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
MLN-4760
Potential treatment - theoretical effect Experimental Antiviral Mar/03/2021
Azanitrile 8
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
Pyridyl ester 17
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/03/2021
hACE221-55A36K-F40E
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021
7-chloro-2-((3,5-dichlorophenyl)amino)quinazolin-4(3H)-one
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021
2-((3,5-dichlorophenyl)amino)-5-hydroxyquinazolin-4 (3H)-one
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/02/2021